FindTrial
Sign In

Venous blood draw

DIAGNOSTIC_TEST4 trials

Sponsors

Vanderbilt-Ingram Cancer Center, Kansas State University, LumiraDx UK Limited

Conditions

5-Fluorouracil ToxicityAnticoagulants and Bleeding DisordersBreast CancerCardiovascularChemotherapy EffectEmbolism and ThrombosisGastrointestinal CancerHead and Neck Cancer

Phase 2

Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
CompletedNCT00930930
Vanderbilt-Ingram Cancer CenterBreast Cancer
Start: 2009-06-30End: 2014-10-31Updated: 2015-05-07

Unknown Phase

Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy
CompletedNCT04042298
Kansas State University5-Fluorouracil Toxicity, Breast Cancer, Chemotherapy Effect +2
Start: 2019-06-25End: 2023-06-01Updated: 2025-09-02
Evaluation of the Accuracy of INR Results From Patients Taking Phenprocoumon as Anticoagulant When Measured Using the Lumiradx INR Test
CompletedNCT04074980
LumiraDx UK LimitedAnticoagulants and Bleeding Disorders
Start: 2019-05-09End: 2019-09-15Updated: 2020-02-20
Collection of Blood Samples for New Diagnostic Devices 2
RecruitingNCT05568966
LumiraDx UK LimitedCardiovascular, Embolism and Thrombosis, Infections +2
Start: 2022-07-11End: 2026-08-20Target: 20000Updated: 2026-03-05

Related Papers

Evaluation of the Accuracy of the LumiraDx INR Test Using Patients in Receipt of Phenprocoumon Anticoagulation Therapy
Point of Care The Journal of Near-Patient Testing & Technology2020-09-01
Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue.
2017-04-0430 citations